Evidence map›Paper›PMID 34819105›Full record

ArticleJournal of translational medicine2021

High efficiency closed-system gene transfer using automated spinoculation.

Victoria Ann Remley, Jianjian Jin, Sarmila Sarkar, Larry Moses, Michaela Prochazkova, Yihua Cai, Lipei Shao, Hui Liu, Tatyana Fuksenko, Ping Jin and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of translational medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Victoria Ann RemleyCenter for Cellular Engineering, Department of Transfusion Medicine, NIH Clinical Center, Bethesda, USA.
Jianjian JinCenter for Cellular Engineering, Department of Transfusion Medicine, NIH Clinical Center, Bethesda, USA.
Sarmila SarkarCenter for Cellular Engineering, Department of Transfusion Medicine, NIH Clinical Center, Bethesda, USA.
Larry MosesCenter for Cellular Engineering, Department of Transfusion Medicine, NIH Clinical Center, Bethesda, USA.
Michaela ProchazkovaCenter for Cellular Engineering, Department of Transfusion Medicine, NIH Clinical Center, Bethesda, USA.
Yihua CaiCenter for Cellular Engineering, Department of Transfusion Medicine, NIH Clinical Center, Bethesda, USA.
Lipei ShaoCenter for Cellular Engineering, Department of Transfusion Medicine, NIH Clinical Center, Bethesda, USA.
Hui LiuCenter for Cellular Engineering, Department of Transfusion Medicine, NIH Clinical Center, Bethesda, USA.
Tatyana FuksenkoCenter for Cellular Engineering, Department of Transfusion Medicine, NIH Clinical Center, Bethesda, USA.
Ping JinCenter for Cellular Engineering, Department of Transfusion Medicine, NIH Clinical Center, Bethesda, USA.
David F StroncekCenter for Cellular Engineering, Department of Transfusion Medicine, NIH Clinical Center, Bethesda, USA.
Steven L HighfillCenter for Cellular Engineering, Department of Transfusion Medicine, NIH Clinical Center, Bethesda, USA. steven.highfill@nih.gov.ORCID http://orcid.org/0000-0003-0135-0961
National Institutes of Health Clinical Center · USInstitute for Transfusion Medicine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGene transfer is an important tool for cellular therapies. Lentiviral vectors are most effectively transferred into lymphocytes or hematopoietic progenitor cells using spinoculation. To enable cGMP (current Good Manufacturing Practice)-compliant cell therapy production, we developed and compared a closed-system spinoculation method that uses cell culture bags, and an automated closed system spinoculation method to decrease technician hands on time and reduce the likelihood for microbial contamination.

methodsSepax spinoculation, bag spinoculation, and static bag transduction without spinoculation were compared for lentiviral gene transfer in lymphocytes collected by apheresis. The lymphocytes were transduced once and cultured for 9 days. The lentiviral vectors tested encoded a CD19/CD22 Bispecific Chimeric Antigen Receptor (CAR), a FGFR4-CAR, or a CD22-CAR. Sepax spinoculation times were evaluated by testing against bag spinoculation and static transduction to optimize the Sepax spin time. The Sepax spinoculation was then used to test the transduction of different CAR vectors. The performance of the process using healthy donor and a patient sample was evaluated. Functional assessment was performed of the CD19/22 and CD22 CAR T-cells using killing assays against the NALM6 tumor cell line and cytokine secretion analysis. Finally, gene expression of the transduced T-cells was examined to determine if there were any major changes that may have occurred as a result of the spinoculation process.

resultsThe process of spinoculation lead to significant enhancement in gene transfer. Sepax spinoculation using a 1-h spin time showed comparable transduction efficiency to the bag spinoculation, and much greater than the static bag transduction method (83.4%, 72.8%, 35.7% n = 3). The performance of three different methods were consistent for all lentiviral vectors tested and no significant difference was observed when using starting cells from healthy donor versus a patient sample. Sepax spinoculation does not affect the function of the CAR T-cells against tumor cells, as these cells appeared to kill target cells equally well. Spinoculation also does not appear to affect gene expression patterns that are necessary for imparting function on the cell.

conclusionsClosed system-bag spinoculation resulted in more efficient lymphocyte gene transfer than standard bag transductions without spinoculation. This method is effective for both retroviral and lentiviral vector gene transfer in lymphocytes and may be a feasible approach for gene transfer into other cell types including hematopoietic and myeloid progenitors. Sepax spinoculation further improved upon the process by offering an automated, closed system approach that significantly decreased hands-on time while also decreasing the risk of culture bag tears and microbial contamination.

Indexed as

Receptors, Chimeric AntigenAntigens, CD19Genetic TherapyHumansImmunotherapy, AdoptiveT-LymphocytesTransduction, GeneticAntigens, CD19Receptors, Chimeric AntigenCAR T-cellGene transferSepaxSpinoculation

Identifiers

PMID34819105
PMCPMC8675485
OpenAlexW3217765951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.